EFFICACY AND SAFETY OF SEBELIPASE ALFA IN CHILDREN AND ADULTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY: RESULTS OF A PHASE 3 TRIAL

dc.contributor.authorRojas-Caro, S.
dc.contributor.authorBaric, I.
dc.contributor.authorCamarena Grande, C.
dc.contributor.authorCoker, M.
dc.contributor.authorDeegan, P.
dc.contributor.authorDiRocco, M.
dc.contributor.authorEzgu, F. S.
dc.contributor.authorFeillet, F.
dc.contributor.authorMalinova, V.
dc.contributor.authorMengel, E.
dc.contributor.authorMurphy, E.
dc.contributor.authorPastor Rosado, J.
dc.contributor.authorRahman, Y.
dc.contributor.authorScarpa, M.
dc.contributor.authorSchwab, K. O.
dc.contributor.authorSmolka, V.
dc.contributor.authorTaybert, J.
dc.contributor.authorValayannopoulos, V.
dc.contributor.authorYang, Y.
dc.contributor.authorQuinn, A.
dc.date.accessioned2019-10-27T22:27:17Z
dc.date.available2019-10-27T22:27:17Z
dc.date.issued2015
dc.departmentEge Üniversitesien_US
dc.description50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver -- APR 22-26, 2015 -- Vienna, AUSTRIAen_US
dc.description.sponsorshipEuropean Assoc Study Liveren_US
dc.identifier.doi10.1016/S0168-8278(15)31407-0
dc.identifier.endpageS811en_US
dc.identifier.issn0168-8278
dc.identifier.issn1600-0641
dc.identifier.startpageS811en_US
dc.identifier.urihttps://doi.org/10.1016/S0168-8278(15)31407-0
dc.identifier.urihttps://hdl.handle.net/11454/50628
dc.identifier.volume62en_US
dc.identifier.wosWOS:000362830900402en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofJournal of Hepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEFFICACY AND SAFETY OF SEBELIPASE ALFA IN CHILDREN AND ADULTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY: RESULTS OF A PHASE 3 TRIALen_US
dc.typeConference Objecten_US

Dosyalar